Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Ophthalmic Drugs Market to reach a value of US$34.3 billion by 2025 – TMR

GlobeNewswire Monday, 7 January 2019
Uptake of Medical Innovations to Boost Sales in Ophthalmic Drugs Market

Albany, New York, Jan. 07, 2019 (GLOBE NEWSWIRE) -- As reported by TMR, the global ophthalmic drugs market is projected to grow at a 4.0% CAGR over the forecast period 2017 to 2025. The market was worth US$24.4 bn in 2016, and is estimated to reach US$34.3 bn by 2025.

On the basis of the disease indication, the segment of retinal disorders is expected to be responsible for a substantial market share over the coming years. This could be on account of a surge in the number of long-term treatment patients.

Geography-wise, North America is predicted to emerge as a leading region in the global ophthalmic drugs market. The high adoption of advanced techniques and novel products is expected to bolster the growth of the market in this region.

*Request to View Sample of Report - *https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1769

*Growing Occurrence of Glaucoma, Macular Degeneration to Spur Growth*

According World Health Organization (WHO) statistics from 2017, roughly 253 million people suffer from vision impairment, out of which 36 million are blind and almost 217 million have moderate to severe vision impairment. Further, the chronic eye disease is reported the primary cause of vision loss, globally. Across the globe, glaucoma is the second leading cause of blindness. Millions of people are victims of age-related macular degeneration. 

On account of the high incidence of eye diseases across the globe, the demand for ophthalmic drugs in projected to amplify. Thus, over the forecast period, the global ophthalmic drugs market is expected to grow substantially.

*Request PDF Brochure of Report - *https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1769

*Introduction of New Ocular Drug Delivery to Boost Opportunity*

In the past, ocular drug delivery was aimed towards obtaining a safe and patient compliant formulation and drug delivery mechanism, which would maintain the tissue drug levels. In present times, various nanoformulations have also been introduced for ocular drug delivery segments. Manufacturers have introduced novel devices and formulations for ocular drug delivery which may reduce associated side effects with conventional drugs such as topical eye drops. The emergence of such innovative technology is expected to create ample growth opportunities in the global ophthalmic drugs market in the coming years. Vendors are expected to leverage novel technology in order to gain traction in the global market.

*Request For Discount On This Report* - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1769

The global ophthalmic drugs market is anticipated to exhibit steady growth in the coming years according to Transparency Market Research (TMR). The market’s competitive landscape features a large number of new market entrants. There exists intense rivalry among the established vendors in the market. Competition is being further amplified by the growing influx of new players in the ophthalmic drugs market.

Key vendors in the global ophthalmic drugs market are focusing on research and development of novel drugs. The vendors are expected to demonstrate an innovative product portfolio in order to maintain their position in the market. Vendors are also likely to invest in the improvement of their distribution channels to gain traction in the global ophthalmic drugs market. Prominent vendors operating in the global ophthalmic drugs market are Genentech, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, and Novartis AG.

*Browse Press Release* - https://www.transparencymarketresearch.com/pressrelease/ophthalmic-drugs-market.htm

This review is based on TMR’s report titled, “*Ophthalmic Drugs Market (Disease Indication – Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders (Wet Age-related Macular Degeneration, Dry Age-related Macular Degeneration, and Diabetic Retinopathy), Allergy, and Uveitis; Therapeutic Class – Anti-inflammatory Drugs (Nonsteroidal Anti-inflammatory Drugs and Steroids), Anti-infective Drugs (Anti-fungal Drugs and Anti-bacterial Drugs), Anti-glaucoma Drugs (Alpha Agonist, Beta Blockers, Prostaglandin Analogs, and Combined Medication), Anti-allergy Drugs, and Anti-VEGF Agents; Product Type – Prescription Drugs and Over-the-Counter Drugs; Distribution Channel – Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies and Drug Stores)* – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025.”

*More Trending Reports by Transparency Market Research:*

· *Hemophilia Treatment Drugs Market - *https://www.transparencymarketresearch.com/hemophilia-treatment-market.html
· *Osteoarthritis Drugs Market - *https://www.transparencymarketresearch.com/osteoarthritis-drugs-market.html
· *Rheumatoid Arthritis Drugs Market - *https://www.transparencymarketresearch.com/rheumatoid-arthritis-drugs.html

*About TMR*

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

*Contact*
Mr. Rohit Bhisey
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
*Email*: sales@transparencymarketresearch.com
*Website:* http://www.transparencymarketresearch.com

Research Blog: http://theglobalhealthnews.com/
0
shares
ShareTweetSavePostSend
 

You Might Like


Recent related news from verified sources

Micron shares rise a tad after chipmaker beats Street's fiscal 2Q forecasts

Shares of Micron Technology (NASDAQ:MU) edged higher in after-hours trade Wednesday after the chip maker overcame a “challenging market” to beat Wall...
Proactive Investors

Archer Exploration produces spherical graphite suitable for lithium battery from Campoona deposit

Archer Exploration Ltd (ASX:AXE) has successfully demonstrated the processing of graphite material from its wholly owned Campoona deposit in South Australia into...
Proactive Investors

Barrick Gold ends hostile takeover bid for Newmont, announces Nevada joint venture

Barrick Gold Corp (NYSE:GOLD) (TSX:ABX) withdrew its unsolicited $17.85 billion bid to acquire Newmont Mining Corporation (NYSE:NEM), the companies announced on...
Proactive Investors

Po Valley Energy intends supplying gas to large Italian market

Po Valley Energy Limited (ASX:PVE) is progressing towards supplying in-demand natural gas to the large Italian market through development of three projects in...
Proactive Investors


Tweets about this


Other recent news in Press Releases

Insight From Cynthia Telles on the Impacts of Obesity on HEALTHAlchemist Mining Announces Definitive Agreement to Purchase Oddyssee SOFTWARE Platform and Share Consolidation
BUSINESS Assets of TE4B Acquired by Version 1 to Enhance Global Delivery Model with Centre of Excellence in BangaloreCloudOak Officially Launches the ''powered by Rubrik'' CUBE for Managed Service Providers Globally, Announces Immediate MSP Growth in CANADA
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.